Fibrilpaint20 directs the ubiquitin–proteasome system to Tau amyloid fibrils
Authors:
- Françoise A. DekkerFDFrançoise A. Dekker
- Júlia Aragonès PedrolaJPJúlia Aragonès Pedrola
- Emile van WeertEWEmile van Weert
- Anne Den BreejenABAnne Den Breejen
- Laura PetersLPLaura Peters
- Guy MayerGMGuy Mayer
- Alfred C.O. VertegaalAlfred C.O. Vertegaal
- Assaf FriedlerAssaf Friedler
- Stefan G. D. RüdigerSRStefan G. D. Rüdiger
- Gobert HeesinkGHGobert Heesink
Preprint
Abstract
Summary: Failure of the Protein Quality Control (PQC) System to control the Tau protein leads to amyloid fibrils that are at the basis of various Tauopathies, including Alzheimer’s Disease (AD). Reinstating the PQC for Tau is desirable. Here we show that the PROTAC peptide FibrilPaint20 (FP20) recruits the ubiquitination system to Tau amyloid fibrils. We reconstituted the ubiquitin-proteasome cascade and monitored the stepwise ubiquitin transfer using the microfluidics technique FIDA. To direct ubiquitination specifically to amyloids, we discovered FP20, a bifunctional peptide that connects amyloid fibrils to the E3 ligase CHIP. FP20 mediated ubiquitination of recombinant and patient derived fibrils from various tauopathies, ultimately enabling the 26S proteasome to target CHIP-ubiquitinated Tau fibrils. This shows that FP20 cooperates with the PQC system and can initiate fibril cleavage. This offers a strategy to target amyloid diseases by cooperation with the PQC system exploiting key cellular systems.Keywords
Funding Information
- Campaign Team Huntington (Senior grant)
- Nederlands ministry of economics
This publication has 119 references indexed in Scilit:
- How do protein aggregates escape quality control in neurodegeneration?Trends in Neurosciences, 2022
- Flow-Induced Dispersion Analysis (FIDA) for Protein Quantification and Characterization2019
- Cryo-EM structures of tau filaments from Alzheimer’s diseaseNature, 2017
- Flow Induced Dispersion Analysis Quantifies Noncovalent Interactions in Nanoliter SamplesJournal of the American Chemical Society, 2010
- Molecular Chaperones and Protein Quality ControlCell, 2006
- Chaperoned Ubiquitylation—Crystal Structures of the CHIP U Box E3 Ubiquitin Ligase and a CHIP-Ubc13-Uev1a ComplexMolecular Cell, 2005
- Ubiquitin Fusion Technology: Bioprocessing of PeptidesBiotechnology Progress, 1997
- Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver diseaseThe Journal of Pathology, 1988
- Structure of ubiquitin refined at 1.8 Å resolutionJournal of Molecular Biology, 1987
- Plaques, tangles and dementiaJournal of the Neurological Sciences, 1982